Literature DB >> 15638229

Platelets: new players in the mucosal scenario of inflammatory bowel disease.

S Danese1, F Scaldaferri, A Papa, R Pola, M Sans, G Gasbarrini, P Pola, A Gasbarrini.   

Abstract

Besides their classical haemostatic task, platelets are now recognized as novel cells deeply involved in inflammation. Compelling evidence support their role as active player in mucosal tissue injury that occurs in Crohn's disease and ulcerative colitis. In both forms of inflammatory bowel disease platelets contribute to microvascular endothelial activation and recruitment of inflammatory cells, thus fostering and amplifying mucosal inflammation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15638229

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  13 in total

1.  Platelets in inflammatory bowel disease.

Authors:  Takayuki Matsumoto
Journal:  J Gastroenterol       Date:  2006-01       Impact factor: 7.527

2.  Platelet activation and platelet-leukocyte aggregation elicited in experimental colitis are mediated by interleukin-6.

Authors:  Serena L S Yan; Janice Russell; D Neil Granger
Journal:  Inflamm Bowel Dis       Date:  2014-02       Impact factor: 5.325

Review 3.  Platelet secretion in inflammatory and infectious diseases.

Authors:  Bhanu K Manne; Shang Chun Xiang; Matthew T Rondina
Journal:  Platelets       Date:  2016-11-16       Impact factor: 3.862

4.  Antiplatelet agents'-ticagrelol and eptifibatide-safety in experimental colitis in mice.

Authors:  Stanko S Petrovic; Milijana M Vasiljevska; Slobodan D Obradovic; Dino K Tarabar; Radoje B Doder; Ivana J Majstorovic; Marijana D Petrovic; Zvonko M Magic; Bojana M Cikota; Nenad J Perisic; Irina A Brcerevic; Nebojsa S Manojlovic; Nemanja K Rancic
Journal:  Turk J Gastroenterol       Date:  2020-06       Impact factor: 1.852

5.  The relationship between neutrophil/lymphocyte and platelet/lymphocyte ratios with oxidative stress in active Crohn's disease patients.

Authors:  F C Eraldemir; M Musul; A E Duman; B Oztas; C Baydemir; S Hulagu
Journal:  Hippokratia       Date:  2016 Oct-Dec       Impact factor: 0.471

6.  Platelet abnormalities during colonic inflammation.

Authors:  Serena L S Yan; Janice Russell; Norman R Harris; Elena Y Senchenkova; Alper Yildirim; D Neil Granger
Journal:  Inflamm Bowel Dis       Date:  2013-05       Impact factor: 5.325

7.  Effect of iron therapy on platelet counts in patients with inflammatory bowel disease-associated anemia.

Authors:  Stefanie Kulnigg-Dabsch; Rayko Evstatiev; Clemens Dejaco; Christoph Gasche
Journal:  PLoS One       Date:  2012-04-10       Impact factor: 3.240

8.  Genome-wide maps of circulating miRNA biomarkers for ulcerative colitis.

Authors:  Radha Duttagupta; Sharon DiRienzo; Rong Jiang; Jessica Bowers; Jeremy Gollub; Jessica Kao; Keith Kearney; David Rudolph; Noor B Dawany; Michael K Showe; Tom Stamato; Robert C Getts; Keith W Jones
Journal:  PLoS One       Date:  2012-02-16       Impact factor: 3.240

9.  A subgroup of first-degree relatives of Crohn's disease patients shows a profile of inflammatory markers in the blood which is more typical of Crohn's disease patients than of normal individuals.

Authors:  Broide Efrat; Goren Iris; Hongbin Wang; Scapa Eitan; Keisari Yona
Journal:  Mediators Inflamm       Date:  2006       Impact factor: 4.711

10.  Evaluation of anti-inflammatory effect of anti-platelet agent-clopidogrel in experimentally induced inflammatory bowel disease.

Authors:  Samir H Patel; Manish A Rachchh; Pinakin D Jadav
Journal:  Indian J Pharmacol       Date:  2012 Nov-Dec       Impact factor: 1.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.